HomeCompareYPHDF vs PLD

YPHDF vs PLD: Dividend Comparison 2026

YPHDF yields 0.38% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.17M in total portfolio value
10 years
YPHDF
YPHDF
● Live price
0.38%
Share price
$367.90
Annual div
$1.39
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$334.3K
Annual income
$221,423.15
Full YPHDF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — YPHDF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYPHDFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YPHDF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YPHDF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YPHDF
Annual income on $10K today (after 15% tax)
$32.04/yr
After 10yr DRIP, annual income (after tax)
$188,209.68/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,279,761.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YPHDF + PLD for your $10,000?

YPHDF: 50%PLD: 50%
100% PLD50/50100% YPHDF
Portfolio after 10yr
$3.42M
Annual income
$2,738,929.67/yr
Blended yield
80.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

YPHDF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
8.5
Piotroski
7/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YPHDF buys
0
PLD buys
0
No recent congressional trades found for YPHDF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYPHDFPLD
Forward yield0.38%3.18%
Annual dividend / share$1.39$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%74.4%
Portfolio after 10y$334.3K$6.50M
Annual income after 10y$221,423.15$5,256,436.18
Total dividends collected$304.7K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: YPHDF vs PLD ($10,000, DRIP)

YearYPHDF PortfolioYPHDF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,775$75.38$11,255$555.24$480.00PLD
2$11,681$151.82$13,062$1,018.59$1.4KPLD
3$12,807$307.64$15,903$1,926.67$3.1KPLD
4$14,334$630.42$20,839$3,823.32$6.5KPLD
5$16,656$1,318.85$30,464$8,166.08$13.8KPLD
6$20,686$2,864.52$52,054$19,457.30$31.4KPLD
7$28,784$6,649.86$109,886$54,188.93$81.1KPLD
8$48,095$17,295.38$304,030$186,451.18$255.9KPLD
9$105,476$54,015.32$1,166,125$840,813.32$1.06MPLD
10$334,283$221,423.15$6,504,190$5,256,436.18$6.17MPLD

YPHDF vs PLD: Complete Analysis 2026

YPHDFStock

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Full YPHDF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this YPHDF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YPHDF vs SCHDYPHDF vs JEPIYPHDF vs OYPHDF vs KOYPHDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.